A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®
Status:
Completed
Trial end date:
2015-01-26
Target enrollment:
Participant gender:
Summary
This was a multicentre, randomised, double-blind controlled study that compared the efficacy
and safety of V. vinifera extract, calcium dobesilate (CD), and placebo in subjects with DME.
Patients made 6 clinic visits, namely the screening visit; baseline visit (T0); and follow-up
visits at 3 (T3), 6 (T6), 9 (T9), and 12 (T12) months.